Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for Advances in Urology, enter your email address in the box below.

Advances in Urology
Volume 2016, Article ID 5392107, 7 pages
http://dx.doi.org/10.1155/2016/5392107
Review Article

Prevalence, Risk Factors, and Clinical Relevance of Fluoroquinolone-Resistant Organisms in Rectal Cultures: Should We Target Antibiotic Prophylaxis Prior to Prostate Biopsy?

J. Van Besien,1 P. Uvin,1 A. M. Van den Abeele,2 and L. Merckx1

1Department of Urology, AZ Sint-Lucas, 9000 Ghent, Belgium
2Department of Microbiology, AZ Sint-Lucas, 9000 Ghent, Belgium

Received 20 September 2015; Accepted 9 February 2016

Academic Editor: Darius J. Bagli

Copyright © 2016 J. Van Besien et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P.-F. Shen, Y.-C. Zhu, W.-R. Wei et al., “The results of transperineal versus transrectal prostate biopsy: a systematic review and meta-analysis,” Asian Journal of Andrology, vol. 14, no. 2, pp. 310–315, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Loeb, A. Vellekoop, H. U. Ahmed et al., “Systematic review of complications of prostate biopsy,” European Urology, vol. 64, no. 6, pp. 876–892, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. E. L. Zani, O. A. Clark, and N. Rodrigues Netto Jr., “Antibiotic prophylaxis for transrectal prostate biopsy,” Cochrane Database of Systematic Reviews, no. 5, Article ID CD006576, 2011. View at Publisher · View at Google Scholar
  4. S. Loeb, H. B. Carter, S. I. Berndt, W. Ricker, and E. M. Schaeffer, “Complications after prostate biopsy: data from SEER-Medicare,” Journal of Urology, vol. 186, no. 5, pp. 1830–1834, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. R. K. Nam, R. Saskin, Y. Lee et al., “Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy,” Journal of Urology, vol. 183, no. 3, pp. 963–969, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Dalhoff, “Global fluoroquinolone resistance epidemiology and implictions for clinical use,” Interdisciplinary Perspectives on Infectious Diseases, vol. 2012, Article ID 976273, 37 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Batura, G. G. Rao, and P. B. Nielsen, “Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy,” BJU International, vol. 106, no. 7, pp. 1017–1020, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Liss, A. Chang, R. Santos et al., “Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy,” Journal of Urology, vol. 185, no. 4, pp. 1283–1288, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Minamida, T. Satoh, K. Tabata et al., “Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy,” Urology, vol. 78, no. 6, pp. 1235–1239, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Steensels, K. Slabbaert, L. De Wever, P. Vermeersch, H. Van Poppel, and J. Verhaegen, “Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy-should we reassess our practices for antibiotic prophylaxis?” Clinical Microbiology and Infection, vol. 18, no. 6, pp. 575–581, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Siriboon, S. Tiengrim, T. Taweemongkongsup, V. Thamlikitkul, and M. Chayakulkeeree, “Prevalence of antibiotic resistance in fecal flora of patients undergoing transrectal ultrasound-guided prostate biopsy in Thailand,” Urologia Internationalis, vol. 88, no. 2, pp. 187–193, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. C. A. Duplessis, M. Bavaro, M. P. Simons et al., “Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates,” Urology, vol. 79, no. 3, pp. 556–561, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. K. Taylor, T. R. Zembower, R. B. Nadler et al., “Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care,” The Journal of Urology, vol. 187, no. 4, pp. 1275–1279, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Taylor, J. Margolick, Z. Abughosh et al., “Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy,” BJU International, vol. 111, no. 6, pp. 946–953, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. M. A. Liss, K. K. Nakamura, R. Meuleners, S. B. Kolla, A. Dash, and E. M. Peterson, “Screening rectal culture to identify fluoroquinolone-resistant organisms before transrectal prostate biopsy: do the culture results between office visit and biopsy correlate?” Urology, vol. 82, no. 1, pp. 67–71, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Qi, M. Malczynski, A. J. Schaeffer et al., “Characterization of ciprofloxacin resistant Escherichia coli isolates among men undergoing evaluation for transrectal ultrasound guided prostate biopsy,” The Journal of Urology, vol. 190, no. 6, pp. 2026–2032, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Suwantarat, D. M. Dumford III, R. Ponce-Terashima et al., “Modification of antimicrobial prophylaxis based on rectal culture results to prevent fluoroquinolone-resistant Escherichia coli infections after prostate biopsy,” Infection Control and Hospital Epidemiology, vol. 34, no. 9, pp. 973–976, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Tukenmez Tigen, Z. Tandogdu, O. Ergonul et al., “Outcomes of fecal carriage of extended-spectrum β-lactamase after transrectal ultrasound-guided biopsy of the prostate,” Urology, vol. 84, no. 5, pp. 1008–1015, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. J. W. Lee, S. C. Park, M. K. Kim, M. W. Cheon, G. Y. Kim, and J.-H. Cho, “Prevalence of antimicrobial resistance in normal rectal flora of patients undergoing transrectal ultrasonography-guided prostate biopsy in Korea,” International Journal of Urology, vol. 21, no. 8, pp. 811–814, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. J. H. Tsu, W. K. Ma, W. K. Chan et al., “Prevalence and predictive factors of harboring fluoroquinolone-resistant and extended-spectrum β-lactamase-producing rectal flora in Hong Kong Chinese men undergoing transrectal ultrasound-guided prostate biopsy,” Urology, vol. 85, no. 1, pp. 15–22, 2015. View at Publisher · View at Google Scholar
  21. M. Y. Hanna, C. Tremlett, G. Josan et al., “Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing transrectal prostate biopsy in Norwich, UK,” BJU International, vol. 116, no. 1, pp. 131–134, 2015. View at Publisher · View at Google Scholar
  22. J. Dai, A. Leone, L. Mermel et al., “Rectal swab culture-directed antimicrobial prophylaxis for prostate biopsy and risk of postprocedure infection: a cohort study,” Urology, vol. 85, no. 1, pp. 8–14, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. S. J. Summers, D. P. Patel, B. D. Hamilton et al., “An antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy,” World Journal of Urology, vol. 33, no. 12, pp. 2001–2007, 2015. View at Publisher · View at Google Scholar
  24. P. R. Womble, S. M. Linsell, Y. Gao et al., “A statewide intervention to reduce hospitalizations after prostate biopsy,” The Journal of Urology, vol. 194, no. 2, pp. 403–409, 2015. View at Publisher · View at Google Scholar
  25. M. A. Liss, W. Kim, D. Moskowitz, and R. J. Szabo, “Comparative effectiveness of targeted vs empirical antibiotic prophylaxis to prevent sepsis from transrectal prostate biopsy: a retrospective analysis,” The Journal of Urology, vol. 194, no. 2, pp. 397–402, 2015. View at Publisher · View at Google Scholar
  26. L. K. Durham, M. Ge, A. J. Cuccia, and J. P. Quinn, “Modeling antibiotic resistance to project future rates: quinolone resistance in Escherichia coli,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 29, no. 3, pp. 353–356, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. E. O. Kehinde, M. Al-Maghrebi, M. Sheikh, and J. T. Anim, “Combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate,” The Journal of Urology, vol. 189, no. 3, pp. 911–915, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Adibi, B. Hornberger, D. Bhat, G. Raj, C. G. Roehrborn, and Y. Lotan, “Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis,” Journal of Urology, vol. 189, no. 2, pp. 535–540, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. D. N. Fish and A. T. Chow, “The clinical pharmacokinetics of levofloxacin,” Clinical Pharmacokinetics, vol. 32, no. 2, pp. 101–119, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. J. P. Horcajada, J. Vila, A. Moreno-Martínez et al., “Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis,” Journal of Antimicrobial Chemotherapy, vol. 49, no. 1, pp. 55–59, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Yagci, F. Yoruk, A. Azap, and O. Memikoglu, “Prevalence and risk factors for selection of quinolone-resistant escherichia coli strains in fecal flora of patients receiving quinolone therapy,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 3, pp. 1287–1289, 2009. View at Publisher · View at Google Scholar · View at Scopus